Get notified of page updates

Prevention study enrolling women ages 25-55 with a BRCA1 mutation

Clinicaltrials.gov identifier:
NCT04711109
PRINTER FRIENDLY PAGE

Denosumab for Breast Cancer Risk Reduction in Women With an Inherited BRCA1 Mutation (The Breast Cancer Prevention Study)

BRCA-P: BRCA1 Breast Cancer Prevention Study.

Prevention study enrolling women ages 25-55 with a BRCA1 mutation

Clinicaltrials.gov identifier:
NCT04711109
PRINTER FRIENDLY PAGE
Glossary on
off

About the Study

NOTE: This study is no longer recruiting patients. 

The BRCA-P Study is an international research study for women who are born with a mutation (change) in one of their genes. The main purpose is to find out if the study medication, denosumab, can decrease the risk of developing breast cancer compared to a (inactive substance) in women with a BRCA1 gene mutation.

 

This Study is Open To:

NOTE: This study is no longer recruiting patients. 

 

This Study is NOT Open To:

NOTE: This study is no longer recruiting patients.